FDA Approves Liquid Marijuana for AIDS and Cancer Patients

liquid THC, pharmaceutical research
Photo by Getty Images

While the United States government refuses to admit the cannabis plant has any real medicinal benefit, its position has not prevented federal health agencies, over the years, from approving synthetic versions of the herb’s psychoactive component to be used by Big Pharma in the treatment of serious conditions.

In fact, the U.S. Food and Drug Administration (FDA), one of the primary barriers in the grand scheme of nationwide legalization, recently approved a liquid variety of synthetic tetrahydrocannabidiol (THC) that will be sold to people suffering from AIDS and cancer.

It was revealed earlier this month that Insys Therapeutics is gearing up to go after a piece of the medical marijuana market, one reportedly worth hundreds of millions of dollars, with a new FDA-approved form of dronabinol. This first-of-a-kind liquid THC synthetic, set to be stocked on pharmacy shelves under the name Syndros, has been given the green light for the treatment of “anorexia associated with weight loss in patients with AIDS, and nausea and vomiting associated with cancer chemotherapy in patients who have failed to respond adequately to conventional antiemetic treatments.”

Although dronabinol, which is commonly referred to under its brand name Marinol, is nothing new to the pharmaceutical industry’s clever approach to capitalizing on marijuana, the latest version is an “easy-to-swallow” liquid designed for quicker absorption than its pill counterpart. A press release issued by Insys indicates that the drug company plans to convert the majority of its dronabinol business over to Syndros by meeting with nearly 8,000 physicians to discuss the benefits of the updated product.

Of course, this laboratory creation has the advantage over the cannabis products being sold in conjunction with state medical marijuana programs because it comes with a Schedule III classification under the Controlled Substances Act—suggesting both medicinal value and a low risk for abuse. The cannabis plant, however, is still ranked with heroin under Schedule I—a classification that deems the herb as having no medical value and a high risk for abuse.

Interestingly, while there are surely some patients out there who prefer taking dronabinol to smoking marijuana, there is significant evidence that shows that plant-based medications are vastly superior to these Big Pharma synthetics because of  a complex cannabinoid/terpene combination known as the “Entourage Effect.” Prescription drugs, like Sydros, are simply test-tube THC, while whole plant medicine can be best described as a wild dance of hundreds of compounds, working together in mysterious combinations to provide the patient with a desired result.

It is for this reason that many patients who have been prescribed dronabinol throughout the past several decades have complained the drug is nowhere near as effective as cannabis.

“When the drug became available in the mid-1980s, scientists thought it would have the same effect as the whole cannabis plant. But it soon became clear that most patients preferred using the whole plant to taking Marinol,” Dr. Sanjay Gupta wrote for CNN back in 2014. “Researchers began to realize that other components, such as CBD, might have a larger role than previously realized.”

But drug companies like Insys and GW Pharmaceuticals, currently on track to bring a CBD-based epilepsy drug called Epidiolex to market, are speaking the federal government’s language when it comes to putting so-called “safe and effective” drugs on the market. By dissecting the cannabis plant to establish a difference between its beneficial and evil components, like one DEA official recently said was happening, drug controllers are able to keep a tight leash on the product, while enabling a place for it in the black market, allowing significant profitability through criminal prosecutions, property seizures and obscene taxes on legal marijuana businesses.

Insys Therapeutics predicts it will generate $700 million annually from the sale of Syndros.

  1. A useless processed chemical and has no healing effects as the real cannabis oil. Just another money maker from big pharma brought to you by the murderous government and it’s regimes. This is nothing short of fraud!

  2. No matter what the DEA do, they are still beating around the bush this is nothing new. Read between the lines synthetic those are not the real ingredients in the genetic plant as a whole so that makes it fake just like K2 and other synthetic forms of medication. This is even more dangerous liquid K2 coming to the neighborhood near you real soon move over liquid codeine there’s a new sheriff in town

  3. Likely they will taint it with something and cause all kinds of medical problems for those using this synthetic garbage. Then in about a year or 2 we will see those ambulance chaser commercials…”If you or a loved one ever used a liquid THC synthetic…then you are probably entitle to compensation…. ” lol

    1. I wonder what else they will be adding to this concoction? We know they don’t seek cures. They want to treat symptoms in order to generate more money. “Love of money is the root if this evil.”

  4. Hypocrisy is par for the course regarding the cancer industry & how it relates to FDA & the other Alphabet soup agencies… My question is, who stands to gain from this, industry wise? Look like FDA & Insys Therapeutic. Agenda clear! Legal for them not for us.
    Trump will attack this corruption because he is not beholding to these good ole boy globalist corrupt systems which control such things.

  5. well processed top 10 medical marijuana for your health.

    Top medical strains for all patients suffering
    from Depression,Glaucoma,Anxiety and Tension,Headaches,Chronic Pain and Nausea,
    Mentaland Physical Fatigue and for Calming Aromatherapy then you are
    in the right place to look in our products all top grade AA+ with high level of CBD and
    THC contact for your supply and good health, just hit me via (Text or email via tonybruzlu@gmail.com or 8322103653

  6. These synthetic cannabinoids are in the same family as Flakka and Bath Salts. Patients take Marinol so they won’t go to jail for cannabis.

  7. It’s Synthetic, so it has NO medical value. of course the FDA approves it, its a chemical companies wet dream set to rake in billions. and like chemo it will solve nothing but making chemical companies richer! fuck that!!!

  8. Hello Mates!!! I’m NEW and after a long search for good stuff, I was Lucky to find a Reliable
    Dealer who supplied me with Quality 1 oz white widow, 1/2 oz AK-47 and 50 grams Cannabis Oil for my
    Cancer & Depression. My delivery was made Safe & Confidential at my Hotel and I’m very impress with
    his quality that is why I am recommending you to Contact Kenneth Bomar if you are Looking for
    Quality Stuff HERE!! Here’s his details,phone (313) 288-9756 / Email kennethbomar95@gmail.com

  9. “People who claim that ?‎marijuana is ?addictive have obviously never spent a ?sleepless night of ?headaches and ?‎nausea lasting for just that little something to take the ?edge off” Thanks to Cannabis Oil Cures and Dr Megan. Cannabis makes life so much easier. It allows you to be comfortable. Here you can contact Dr Megan via dr.megan.ann@gmail.com if interested in Medical Cannabis or Cannabis OIl.

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts